Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $82,500 | 7 | 98.6% |
| Food and Beverage | $895.77 | 13 | 1.1% |
| Travel and Lodging | $239.69 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ExThera Medical Corporation | $82,500 | 7 | $0 (2024) |
| GENZYME CORPORATION | $429.95 | 2 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $272.74 | 4 | $0 (2024) |
| ABBVIE INC. | $166.67 | 3 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $102.86 | 1 | $0 (2017) |
| Myriad Women's Health, Inc. | $96.77 | 1 | $0 (2023) |
| Gilead Sciences Inc | $28.75 | 1 | $0 (2017) |
| Sandoz Inc. | $20.68 | 1 | $0 (2019) |
| CSL Behring | $17.04 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82,577 | 8 | ExThera Medical Corporation ($82,500) |
| 2023 | $162.46 | 2 | Myriad Women's Health, Inc. ($96.77) |
| 2022 | $136.72 | 2 | ABBVIE INC. ($136.72) |
| 2021 | $29.95 | 1 | AbbVie Inc. ($29.95) |
| 2020 | $17.04 | 1 | CSL Behring ($17.04) |
| 2019 | $581.12 | 5 | GENZYME CORPORATION ($429.95) |
| 2017 | $131.61 | 2 | BOSTON SCIENTIFIC CORPORATION ($102.86) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ExThera Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 11/26/2024 | ExThera Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 11/01/2024 | ExThera Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 09/20/2024 | ExThera Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 09/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $76.56 | General |
| Category: Gastroenterology | ||||||
| 08/29/2024 | ExThera Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 07/31/2024 | ExThera Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 07/31/2024 | ExThera Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 11/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $65.69 | General |
| Category: Gastroenterology | ||||||
| 04/25/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $96.77 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $106.72 | General |
| 04/06/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/01/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/11/2020 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Immunology | ||||||
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $239.69 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $190.26 | General |
| 04/08/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/16/2019 | Sandoz Inc. | TREPROSTINIL (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: PULMONARY ARTERIAL HYPERTENSION | ||||||
| 01/08/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $103.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - BILIARY DEVICES (Device) | Food and Beverage | In-kind items and services | $102.86 | General |
| Category: BILIARY DEVICES | ||||||
| 10/25/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $28.75 | General |
About Dr. Michael Lewis, M.D
Dr. Michael Lewis, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306047139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Lewis, M.D has received a total of $83,635 in payments from pharmaceutical and medical device companies, with $82,577 received in 2024. These payments were reported across 21 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($82,500).
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location Los Angeles, CA
- Active Since 05/30/2007
- Last Updated 06/22/2024
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306047139
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $429.95
- XIFAXAN (Drug) $272.74
- GENERAL - BILIARY DEVICES (Device) $102.86
- MYRISK (Device) $96.77
- CREON (Drug) $30.00
- LINZESS (Drug) $29.95
- TREPROSTINIL (Drug) $20.68
- Haegarda (Biological) $17.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Los Angeles
Serge Alexanian, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $2.4M
Brian Cone, D.o, D.O
Anatomic Pathology & Clinical Pathology — Payments: $325,661
Mark Haas, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $140,393
Dr. Nam Ku, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $79,867
Jonathan Braun, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $73,284
Dr. Jess Savala, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $35,937